TNF and COVID-19: The current study showed that patients under CHD hospitalized for moderate COVID-19 have increased circulating levels of TNFα, IFNγ and PDGF-A, decreased CD14-lymphocytes, decreased CD19-lymphocytes and decreased expression of HLA-DR on CD14-monocytes.